Name: Brain Disorders 2024
Start: 2024-04-18
End: 2024-04-20
Location: Dubai

Conference Information

Invitation

On behalf of the organizing committee, we are glad to announce and invite you to the international conference on Brain Disorder 2024 scheduled as a Hybrid Conference with the support of the eminent speakers at the past series. The conference Brain Disorder was officially entitled 9th Annual Conference on Brain Disorders, Neurology, and Therapeutics from April 18-19, 2024 in Dubai, UAE.

Here, Brain Disorders 2024 plans to organize this conference with the theme of Emerging Challenges and advancements in Brain Disorders. We have an innovative & and interesting program planned for this year's conference that will provide participants a chance to reflect on and share their knowledge with the other speakers. It will broaden networks and cooperatively investigate current and prospective future research paths. We hope that it will provide our participants with an outstanding enlightening and knowledge-gaining session.

The program was previously intended to provide good networking chances, and creating an interactive session will be beneficial. and we expect that the importance of various countries will assist this conference in maintaining a look that is much more suited for the Excellent Meeting of Brain Disorders in the year 2024.

I hope you will use this ability to attend this thought-provoking conference in Dubai, UAE.

Market Analysis

The global Brain disease modalities and software market report highlights that the market was valued at $13,055.7 million in 2021 and is expected to reach $21,867.6 million by the end of 2031. The market is expected to grow at a CAGR of 5.31% during the forecast period from 2022 to 2031.

Brain Disorders patients throughout Europe are being tasked with the delivery of increasingly more complex treatments and supportive care interventions due to ongoing advances in Neurology research, and an upward thrust in most cancers’ incidence because of demographic modifications. However, all fitness systems delivering most brain remedy innovations require to get admission to an educated and inspired nursing staff to meet the call for.

This examines by way of the Alzheimer association, examines the comparative functions of most cancers nursing in Estonia, Germany, the Netherlands (NL), and the United Kingdom (UK).

In keeping with the U.S. Authority of hard work records', the middle national yearly pay for legal reasons and licensed qualified Nurses is $69,480. Whereas a licensed vocational nurse can earn $58,000. Actual pay costs may range extraordinarily considering their Specialization in the discipline, place, years of enjoyment and an Assortment of various variables. Approaching studies efforts will be more suitable by means of interdisciplinary association and the advent of international nursing studies centers. At one pass, we want to stay Cognizant of the position of mentoring upcoming nursing research.

The research provides market share information for Neurology according to several illness indications. Parkinson diseases, Alzheimer diseases, psychotic disorders, epilepsy disorders, autism disorders, and brain tumor diseases are the different categories of neurological illnesses on the market. Regional analyses and therapies are covered for each illness segment.

Anti-medication Parkinson's is provided in the Parkinson Diseases market. The market is divided by drug class and geographic region. The market is divided into dopaminergic, enzyme inhibitors, dopamine agonists, and other anti-drugs Parkinson's based on drug class. The market is divided into North America, Europe, Asia-Pacific, South America, Middle East, and Africa based on region.

The introduction of new Parkinson's disease treatment products will help the market expand to its full potential. Adamas Pharmaceuticals, Inc. published subgroup analyses of Parkinson's disease patients enrolled in EASE LID 2 who are still suffering dyskinesia and using amantadine immediate release (IR). The GOCOVRITM (amantadine) extended-release capsule results of the ongoing phase 3 open-label research indicate that there are around 35% improvements in motor applications. This patient's safety and tolerability profile was observed to be consistent and free of any negative effects. A strong therapeutic pipeline for the treatment of Parkinson's disease is another asset shared by the majority of the big competitors.

Anti-Alzheimer medications are provided in the Alzheimer Diseases market. Based on the drug's mode of action and the geography, the market is divided into segments. The market is divided into NMDA antagonists and AChE inhibitors depending on pharmacological class. The market is divided into three regions based on geography: North America, Europe, and the Rest of the World.

With a market share of over 34% in 2020, the Alzheimer's disease application sector is anticipated to maintain its dominance throughout the next years. The high prevalence of the disease and the accessibility of clinically useful items, such as imaging biomarkers - amyloid PET tracers for diagnosis are credited with this increase. Additionally, a wide range of research possibilities are being offered by the government and nonprofit institutions, which could spur industry expansion. The Michael J. Fox Foundation for Parkinson's Research (MJFF), Alzheimer's Research U.K., the Weston Brain Institute, and the Alzheimer's Association developed Biomarkers Across Neurodegenerative Diseases (BAND), which provides funding for biomarker discovery research.

Antipsychotic medications are introduced on the market for psychotic illnesses. The market is divided by drug class and geographic region. The market is divided into D2 antagonists, D2/5HT2A antagonists, and D2 partial agonists based on the kind of medicine. The market is divided into North America, Europe, Asia-Pacific, South America, Middle East, and Africa based on region.

Anti-epileptic medications are sold in the epileptic diseases market. The market is divided by drug class and geographic region. The market is divided into first generation pharmaceuticals, second generation medications, and third generation drugs based on the drug class. The market is divided into North America, Europe, Asia-Pacific, South America, Middle East, and Africa based on region.

Autistic disorder medicines are included in the market for autism disorder. Drugs are divided into market segments depending on labelled information and geographic location. The market is divided into ASD-labeled drugs and Off-label pharmaceuticals based on the pharmacological class. The market is divided into three regions based on geography: North America, Europe, and the Rest of the World.

Brain tumor therapies are included in the market for brain tumors. Therapy type and geography are the market segments. The market is divided into chemotherapy and targeted therapy based on the kind of therapy. The market is divided into North America, Europe, Asia-Pacific, and the Rest of the World based on region.

Here, In the future years there is a large scope for the oncology nurses. And also, it is adversely beneficial for the treatment for the brain disorder patients. The ideal analysis for the huge success of this annual Series was set by Brain Disorder 2024.

About Conference

The International Conference on Brain Disorders and Neurology is a remarkable conference put on by an academic group with the goal of advancing the knowledge, implementation, documentation, and awareness of Brain Disorders worldwide. The organizing committee designed engaging seminars, symposiums, exhibitions, and workshops to accomplish these objectives. This will be covered in the Yearbook of Brain Disorder and released in our Journal as a Special Issue.

The Conference, which will bring together researchers from academic institutions and industry and encourage professional interactions between people, will offer an opportunity for the presentation of updated results related to both theoretical and applied research in the field of brain research and therapies, etc. A two-day virtual event on the most important and recent arguments about the relationship between professionals and the world was also included in the conference.

Last year, Brain Disorder 2022 was organized in the Virtual mode. It created a great impact on our healthcare professionals. Likewise, we plan to organize this series as a great event with the help of academic speakers, professors, researchers, PhD students, and industrial people.

We are looking forward to presenting new and intriguing results alongside excellent professionals from all around the world at this event, which will be a magnificent conference on Brain Disorders from April 18 to April 19, 2024, in a wonderful venue like Dubai, UAE.

Why to Attend?

Brain Disorders 2024 is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, and scholars to exchange state-of-the-art research and technologies.

The aim of this conference is to stimulate new ideas for treatment that will be beneficial across the spectrum of Brain Disorders and engage with phenomenal scholars across the world.

The sessions of the Brain Disorders Conference set a highly advanced, innovative, and valuable contribution to our medical professions for all who work in contact with brain diseases and Neurological Disorders on a daily basis

Who Should Attend?

Academic Scientists
Neuro-oncologist
Neurologist
Physiatrist
Rehabilitation therapist
Physician
Professor’s
Researchers
Intellectuals
Students
Research scholars
Intellectuals CEOs, directors of organizations
Medical Colleges & Universities Facuilty
Associations & Societies
Researchers and Faculty Members
Business Delegates
Students and Research Scholars
Scientists and Professors
Students, Interns and Residents
Directors/Managers/CEO’s

About Brain Disorders 2022

Upon the successful completion of 2021 series, we would like to extend our gratefulness to all of our admirable keynote speakers, conference attendees, students, associations, media partners, exhibitors, and delegates who made the Brain Disorder 2021 a booming success.

Here we gathered with more than 200+ participants who attended the Brain Disorder 2021 among those 70% of attendees were from industrial divisions and around 30% from Academia circumstances.

Furthermore, 10+ keynote and over 30 plenary speakers shared their findings on brain injury, brain disorder, neurology, neuroscience, neuroimaging mental health and neurological disorders, therapeutics, and much more in over 14 Innovative Educational Sessions compiled with commendable audience participation. Accompanied with 3+ Exhibitors and multiple B2B conferences, it resulted in an exemplary success of the event.

We would also like to thank our Organizing Committee Members and our Keynote Speakers comprising

Alfredo Munoz Gaona | Center for Neuro-Regenerative Medicine | Spain

Rebecca Jackson | Brain Balance Achievement Centers | USA

Soraya L Valles | University of Valencia | Spain

Owen Connolly | Owen Connolly Counseling Therapy & Education Centre | Ireland

For their support in making this event a great success. We would also like to thank our Moderator Dr. Constanza Aldasoro Sanchis., "The University of Valencia, Spain" for being a great support for our event to be a grand success. I hope that Brain Disorders 2024 will be a noteworthy one.

Abstract Sessions

Session 01: Neurological Disorders & Stroke

A Stroke and Neurological Disorders occurs when the blood force to part of the brain is suddenly intruded or when a blood vessel in the brain bursts, discovering blood into the spaces girding brain cells. Brain cells die when they no longer admit oxygen and nutrients from the blood or there's unforeseen bleeding into or around the Brain. When the brain, the spinal cord, and the nerves that run throughout the human body are affected, it is said to have Neurological Disorders. Further Details addressed at Brain Disorders Conference.

Ischemic stroke
Hemorrhagic stroke
Transient ischemic attack

Related Societies: International Behavioral Neuroscience Society (IBNS) | International Neuroethics Society (INS) | International Society for Invertebrate Neurobiology (ISIN) | International Society of Neuropathology (ISN) | International Society of Psychoneuroendocrinology (ISPNE) | Bulgarian Neuroscience Society | Croatian Society for Neuroscience | German Neuroscience Society

Session 02: Brain Injury

Brain Injury - An object that goes through Brain towel, similar as a pellet or shattered piece of cranium, also can beget traumatic brain injury. Mild traumatic brain injury affects your brain cells temporarily. More-serious traumatic brain injury can affect in bruising, bleeding and other physical damage to the Brain. Traumatic brain injury (TBI) happens when a sudden, external, physical assault damages the brain. Join us at Brain Disorders 2023 Conference for more updates.

Penetrating brain injury
Closed brain injury

Session 03: Amyloid and Tau Protein

In Neurology, Amyloid- β peptides are proteolytic fractions of the transmembrane amyloid precursor protein, whereas tau is a brain-specific, axon- amended microtubule- associated protein.

Tau is another substance that builds up in Alzheimer's Disease complaint and damages brain cells essential for literacy and memory. Tau buildup is caused by increased exertion of enzymes that act on tau called tau kinases, which causes the tau protein to misfold and clump, forming neurofibrillary befuddlements. Join us at Brain Disorders 2023 Conference for more updates.

Familial ATTR Amyloidosis
Wild-Type (Senile) ATTR Amyloidosis

Session 04: Demyelinating disease

By the study of Neuroscience, a demyelinating complaint is any condition that causes damage to the defensive covering (myelin jacket) that surrounds whim-whams filaments in your brain, the jitters leading to the eyes (optical) and spinal cord. When the myelin sheath is damaged, whim-whams impulses slow or indeed stop, causing Neurological Disease. which will further discussed at Brain Disorders Conference 2023.

Gullain-Barre
Transverse Myelitis
Clinically Isolated Syndrome

Related Societies: Sociedad Argentina de Investigacion en Neurociencias | Sociedade Brasileira de Neurociencias e Comportmento | Sociedad Chilena de Neurociencia | Colegio Colombiano de Neurociencias (COLNE) | Cuban Neuroscience Society | Federation of Neuroscience Societies of Latin America and the Caribbean (FALAN) | Sociedad Mexicana de Ciencias Fisiológicas | Society for Neuroscience of Peru (SONEP) | Sociedad de Neurociencia del Uruguay | Sociedad Venezolana de Ciencias Fisiológicas

Session 05: Spine Disorders

Spinal cord diseases are conditions that beget damage and deterioration to the spinal cord. Spinal conditions frequently beget pain when bone changes put pressure on the spinal cord. They can also limit movement. Neurologically, treatments differ by complaint, but occasionally they include back braces and surgery. For further details, addressed at Brain Disorders 2023.

Arthritis
Herniated disc
Spondylosis

Session 06: Rehabilitation post-trauma

Neurorehabilitation is helping a person recover from a major traumatic injury by taking a whole- person, multidisciplinary approach. Traumas frequently do as a result of a motor vehicle accident, but have numerous other causes as well including plant injuries, serious medical conditions, sports injuries and further. Treatments for Neurological conditions vary depending on the complaint, although they occasionally involve back braces and surgery. Addressed at the Brain Disorders Conference for further information.

Occupational therapy
Speech and language therapy
Physical therapy

Session 07: Pediatric Neurology

Pediatric neurology refers to a technical branch of drug that deals with the opinion and operation of neurological conditions in babes(babe), babies, children, and adolescents. Pediatric neurology, sometimes known as child neurology, is the study of brain, spinal cord, peripheral nerve, and muscle conditions that affect newborns, kids, and teenagers. Join us at Brain Disorders 2023 to learn more.

Autism
Dyslexia
Cerebral Palsy

Related Societies: International Neuroethics Society (INS) | International Neuroinformatics Coordinating Facility (INCF) | International Society for Invertebrate Neurobiology (ISIN) | International Society of Neuropathology (ISN) | International Society of Psychoneuroendocrinology (ISPNE) | International Union of Physiological Sciences (IUPS) | Association pour la Promotion des Neurosciences (APRONES) | Kenya Society for Neurosciences | Mediterranean Neuroscience Society

Session 08: Cognitive Neuropsychiatry

Cognitive Neuropsychiatry is a growing multidisciplinary field arising out of cognitive psychology and neuropsychiatry that aims to understand internal illness and psychopathology in terms of models of normal cerebral function. Cognition denotes a fairly high position of processing of specific information including thinking, memory, perception, provocation, professed movements and language. which will further discussed at Brain Disorders Conference 2023.

Thought and Language Disorder
Conversion Disorder
Delusions

Session 09: Neurodegeneration & Aging Disorders

Ageing is the main threat factor for utmost neurodegenerative conditions, including Alzheimer’s Disease complaint(announcement) and Parkinson’s Disease complaint (PD). Tissues composed primarily of postmitotic cells, similar as the brain, are especially sensitive to the goods of ageing. The most common age- related neurodegenerative complaint, Alzheimer's complaint(announcement), affects the entorhinal cortex profoundly and beforehand in the complaint, contributing to cardinal symptoms of short- term memory loss and learning.

Parkinson Diseases
Dementia
Patho psychology

Related Societies: Ageing and Dementia Research Group (ADRG), Sultan Qaboos University, Oman | Neuroscience Group, United Arab Emirate | Academia de Ciencias de América Latina (ACAL) | Sociedad Argentina de Investigacion en Neurociencias | Sociedade Brasileira de Neurociencias e Comportmento | Sociedad Chilena de Neurociencia | Colegio Colombiano de Neurociencias (COLNE)

Session 10: Brain Tumors

A brain excrescence is a mass or growth of abnormal cells in your brain. numerous different types of brain excrescences live. Some brain excrescences are noncancerous(benign), and some brain tumor are cancerous(nasty). In Neurology, Brain and spinal cord excrescences, like other excrescences, are caused by changes in the DNA inside cells. DNA is the chemical that makes up our genes, which control how our cells serve. We generally look like our parents because they're the source of our DNA. But DNA affects further than how we appear.

Choroid Plexus Tumor
Pituitary Adenoma
Dysembryoplastic Neuroepithelial Tumor

Session 11: Down syndrome

Down syndrome is a condition in which a person has a redundant chromosome. Chromosomes are small “packages” of genes in the body. They determine how a baby's body forms and functions as it grows during gestation and after birth. Normally, a baby has born with 46 chromosomes.

Trisomy 21
Translocation Down syndrome
Mosaic Down syndrome

Session 12: Epilepsy

Epilepsy is a central nervous system (neurological) complaint in which brain exertion becomes abnormal, causing seizures or ages of unusual geste, sensations and occasionally loss of mindfulness. Anyone can develop epilepsy. Epilepsy affects both males and ladies of all races, ethnical backgrounds and periods.

Generalized epilepsy
Focal epilepsy

Related Societies: Canadian Association for Neuroscience | Canadian Institute of Neuroscience, Mental Health & Addiction (INMHA) | National Academy of Sciences (US) | Society for Neuroscience | The Dana Foundation | International Behavioral Neuroscience Society (IBNS) | International League Against Epilepsy (ILAE) | International Neuroethics Society (INS) | International Neuro informatics Coordinating Facility (INCF)

Session 13: Multiple sclerosis

Multiple sclerosis is a chronic complaint that affects the central nervous system, which is the brain, spinal cord, and optical nerves. This can lead to a wide range of symptoms throughout the body. Scientists don't know exactly what causes Multiple Sclerosis, but they believe Trusted Source it's an autoimmune complaint that affects the Central Nervous System (CNS). When a person has an autoimmune complaint, the immune system attacks healthy tissue, just as it might attack a contagion or bacteria.

Clinically isolated syndrome
Relapse-remitting MS

Session 14: Alzheimer’s disease

Alzheimer’s complaint is a brain complaint that sluggishly destroys memory and thinking chops and, ultimately, the capability to carry out the simplest tasks. In utmost people with the complaint, those with the late- onset type symptoms first appear in theirmid-60s. The causes presumably include a combination of age- related changes in the brain, along with inheritable, environmental, and life factors. The significance of any one of these factors in adding or dwindling the threat of Alzheimer's complaint may differ from person to person.

Early-Onset Alzheimer
Late-Onset Alzheimer
Familial Alzheimer

Session 15: Neuro-oncology

Neuro- oncology is a branch of drug that concerns cancers of the brain and spinal cord. Cancers of the nervous system are frequently severe conditions that ultimately come life hanging. The Neuro- Oncology Program investigates the mechanisms of brain excrescence biology and researches forestallment and treatment strategies for primary and secondary brain oncology, with a thing of perfecting survival and quality of life for cases with brain excrescences.

Anaplastic astrocytoma
Brain metastases
Brain stem glioma

Session 16: Neuropsychology and Psychiatry

Neuropsychology is the discipline which investigates the relations between brain processes and mechanisms on one hand, and cognition and behavioral control on the other. Neuropsychology is a branch of psychology. It's concerned with how a person's cognition and behavior are related to the brain and the rest of the nervous system. Professionals in this branch of psychology frequently concentrate on how injuries or illnesses of the brain affect cognitive and behavioral functions. Interdisciplinary group of psychiatrists, clinical psychologists, forensic psychologists, neuropsychologists, occupational psychologists and health psychologists based within the Institute of Mental Health and enjoying close links with topics related to the neurosciences and the behavioral sciences.

Tourette Syndrome
Traumatic Brain Injury

Session 17: Behavioral Sciences

In Neurology, Behavioral scientists’ study when and why individualities engage in specific actions by experimentally examining the impact of factors similar as conscious studies, provocation, social influences, contextual goods, and habits. Several disciplines fall under the broad marker of behavioral wisdom, including Anthropology. Further addressed at Brain Disorders 2023 Congress.

Cognitive science
Psychobiology
Neural networks

Session 18: Mental disorder / Mental illness

Mental health is the foundation for feelings, allowing, communication, literacy, adaptability and tone- regard. Mental health is also crucial to connections, particular and emotional well- being and contributing to community or society. Numerous people who have an internal illness don't want to talk about it. But internal illness is nothing to be ashamed of. It's a medical condition, just like heart complaint or diabetes. And internal health conditions are treatable. We're continually expanding our understanding of how the mortal brain workshop, and treatments are available to help people successfully manage internal health conditions.

Psychotic Disorders
Personality Disorders
Anxiety Disorders

Session 19: Anxiety disorder’s & Depression

Women experience depression more frequently than do males. Based on sex and age, some distinctions in how the melancholy mood presents themselves have been discovered. It frequently shows up in men as fatigue, irritation, and rage. They might behave more recklessly and engage in drug and alcohol misuse. Additionally, they frequently do not acknowledge their depression and do not get therapy. Depression frequently shows up in the form of sadness, worthlessness, and guilt in women. Depression is more likely to show up in younger children as school refusal, separation anxiety, and parent-related anxiety. Further information addressed at Brain Disorders 2023 Congress.

Bipolar disorder
Persistent depressive disorder
Premenstrual dysphoric disorder

Session 20: Inflammatory Neurologic Diseases

Inflammatory Neurologic Diseases that manifest in the brain in a variety of ways can be brought on by systemic inflammation. People may develop cognitive symptoms like confusion or memory loss. Other typical signs, or "illness behavior," could be: Depression. Brain fog, or the sensation of thinking slowly and erratically, is one of the most prevalent signs of brain inflammation. Other typical signs of brain inflammation include fatigue, melancholy, anxiety, irritability, and aggression.

Acute disseminated encephalomyelitis
Acute Optic Neuritis
Transverse Myelitis

Session 21: Addiction & Therapeutics

Addiction is a brain disease that manifests as compulsive behavior because alterations in brain structure and function are key to its development and expression. The mesolimbic dopamine pathway is the area of the brain that drives addiction. The brain's reward circuit is another name for it. The brain receptors of an addicted person are overloaded. The brain adjusts in a manner akin to turning down a loudspeaker when the volume is too high by either creating less dopamine or by eradicating dopamine receptors.

Substance abuse
Substance dependence
Chemical dependence

Session 22: Ethics in Neurology and Legal Issues

Neuroethical concerns have emerged that fall into two categories: On the one hand, new methodologies and techniques pose issues for individual rights to privacy, non-interference, and inviolability by exposing brain correlates of human identification. In the ethics Neurology, legal concerns deal with laws governing people within a community, state, or nation, whereas ethical issues deal with norms or laws governing the behavior of members of a profession. Join us at Brain Disorders Conference 2023 for more updates.

Informed Consent
Prevent harm
Protect the vulnerable

Session 23: Animal models of Neurobehavioral Disorders

The foundation of Animal Models is the notion that numerous animal species share behaviors or diseases with humans. Rodents, fruit flies, C. elegans worms, non-human primates, and other animals are used by scientists to study many facets of brain function and behavior. In all fields of biomedical research, Animal Models are essential. Despite the long history of utilizing animal models in the examination of Neuropsychiatric illnesses and behavioral dysfunctions, the process of animal model design, development, and evaluation has seldom been addressed in a systematic manner. The development and evaluation of animal models is proposed as an iterative, multi-stage process. The first step in the process is to decide what the model's purpose(s) will be, preferably based on theories regarding the connections between brain and behavior. The model is then created and put to the test. Scientific and moral standards are taken into account in the model's evaluation.

Disease induction models
Xenograft animal models
Inbred strains
Transgenic models

9th Annual Conference on
Brain Disorders, Neurology and Therapeutics

Quick Links

Theme: Emerging Challenges and advancements in Brain Disorders

Conference Information

Invitation

Market Analysis

About Conference

Abstract Sessions